Menu
Back to User profile » Dr Wilson Liao
Papers published by Dr Wilson Liao:
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
Spencer RK, Jin JQ, Elhage KG, Davis MS, Liao W, Bhutani T
Psoriasis: Targets and Therapy 2023, 13:59-69
Published Date: 25 October 2023
Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
Jin JQ, Spencer RK, Reddy V, Bhutani T, Liao W
Therapeutics and Clinical Risk Management 2023, 19:413-423
Published Date: 18 May 2023
Psoriasis and Exercise: A Review
Yeroushalmi S, Hakimi M, Chung M, Bartholomew E, Bhutani T, Liao W
Psoriasis: Targets and Therapy 2022, 12:189-197
Published Date: 2 July 2022
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
Chung M, Bartholomew E, Yeroushalmi S, Hakimi M, Bhutani T, Liao W
Psoriasis: Targets and Therapy 2022, 12:151-176
Published Date: 22 June 2022
The Role of IL-17 Cytokines in Psoriasis
Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T
ImmunoTargets and Therapy 2021, 10:409-418
Published Date: 24 November 2021
Biologic Treatments of Psoriasis: An Update for the Clinician
Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J
Biologics: Targets and Therapy 2021, 15:39-51
Published Date: 16 February 2021
Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
Reddy V, Yang EJ, Myers B, Liao W
Journal of Inflammation Research 2020, 13:53-60
Published Date: 22 January 2020
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
Ly K, Beck KM, Smith MP, Orbai AM, Liao W
Psoriasis: Targets and Therapy 2019, 9:97-107
Published Date: 28 August 2019
Acrodermatitis continua of Hallopeau: clinical perspectives
Smith MP, Ly K, Thibodeaux Q, Bhutani T, Liao W, Beck KM
Psoriasis: Targets and Therapy 2019, 9:65-72
Published Date: 9 August 2019
Secukinumab in the treatment of psoriasis: patient selection and perspectives
Yang EJ, Beck KM, Liao W
Psoriasis: Targets and Therapy 2018, 8:75-82
Published Date: 17 October 2018
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
Beck KM, Sanchez IM, Yang EJ, Liao W
Psoriasis: Targets and Therapy 2018, 8:49-58
Published Date: 29 August 2018
The impact of genital psoriasis on quality of life: a systematic review
Yang EJ, Beck KM, Sanchez IM, Koo J, Liao W
Psoriasis: Targets and Therapy 2018, 8:41-47
Published Date: 28 August 2018
The metabolomics of psoriatic disease
Yan D, Afifi L, Jeon C, Trivedi M, Chang HW, Lee K, Liao W
Psoriasis: Targets and Therapy 2017, 7:1-15
Published Date: 31 January 2017
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W
Psoriasis: Targets and Therapy 2016, 6:93-104
Published Date: 20 July 2016